Skip to main content
. 2022 Nov 18;10(2):2204598. doi: 10.1002/advs.202204598

Figure 6.

Figure 6

EG7‐OVA tumor growth. a) On day 0, C57BL/6 female mice were injected with EG7‐OVA cells (1 × 106). On days −7, 1, and 7, a total of three subcutaneous injections with PBS, free OVA, TCCSia‐Ace‐Dex‐OVA‐Rd (17) or PEG‐Ace‐Dex‐OVA‐Rd (19) with the same amounts of OVA (100 µg) were given. b) Growth curves of tumors in mice were collected. On day 11, the mice were sacrificed by anesthesia. c) Photographs of the dissected tumors were taken, and d) the dissected tumors were weighed. e) The average body weight of tumor‐bearing mice was monitored over time. The error bars represent the SEM (b) or SD (d) of six mice for each group. The p value was obtained by two‐way ANOVA Bonferroni posttest (b) or a two‐tailed t‐test (d) with GraphPad Prism 8. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.